LeMaitre Vascular
LMAT
154 hedge funds and large institutions have $511M invested in LeMaitre Vascular in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 14 closing their positions.
100% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 14
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
14% more capital invested
Capital invested by funds: $448M → $511M (+$63.2M)
8% more funds holding
Funds holding: 142 → 154 (+12)
8% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 49
0.18% more ownership
Funds ownership: 73.01% → 73.19% (+0.18%)
Top Buyers
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$5.2M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$4.99M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.57M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.19M |
| 5 |
Renaissance Technologies
New York
|
-$1.72M |
LMAT Hedge Fund Activity: Q1 2018 in Review
154 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2018, worth a combined $511M — up 14% from $448M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new LMAT positions and 14 closed out — a net gain of 14 holders — while 53 added to existing stakes and 49 trimmed.
The largest buyer was Ameriprise, adding an estimated $4.22M. The largest seller was AWM Investment Company, cutting an estimated $5.2M.
- 154 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2018, up from 142 in Q4 2017.
- Funds reported $511M of LeMaitre Vascular stock for Q1 2018, up 14% quarter-over-quarter.
- 28 funds opened new LeMaitre Vascular positions in Q1 2018 and 14 closed out, a net change of +14 holders.
- The largest LeMaitre Vascular buyer in Q1 2018 was Ameriprise, an estimated $4.22M added.
- The largest LeMaitre Vascular seller in Q1 2018 was AWM Investment Company, an estimated $5.2M sold.
Based on aggregated 13F filings for Q1 2018.